Earnings

LeMaitre Vascular Sees Q3 GAAP EPS $0.66-$0.71 vs $0.73 Est; Sees Sales $66.300M-$68.300M vs $69.246M Est

Aug 4, 2026 · 04:25 PM ET· updated 2h ago

LeMaitre Vascular (NASDAQ:LMAT) is looking for Q3 GAAP EPS of $0.66-$0.71 vs $0.73 analyst estimate. sees sales of $66.300 million-$68.300 million vs $69.246 million analyst estimate.

Why It Matters

LeMaitre Vascular expects to earn less money per share and bring in less total sales than experts predicted for the next quarter. When a company misses what people expected, it's worth watching to see if they explain why and whether this is just one bad quarter or a bigger problem.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

LMAT97.95

-5.66 (-5.46%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.